Skip to main content
Log in

Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Three cases of cerebrospinal fluid (CSF) leak, in subjects with an invasive macroprolactinoma under treatment with cabergoline (CAB), are reported. The patients underwent surgical treatment by means of an endoscopic endonasal transsphenoidal approach, which allowed removal of the lesion and sealing of the fistula. Many cases of CSF rhinorrhea are described in literature after bromocriptine therapy in invasive prolactinomas, but only one report has been recently published of such condition after CAB treatment. The complication is likely due to the brisk cessation of the so-called “stopper effect”, i.e. the tumor mechanically blocking the CSF leak in spite of its previous erosion of the skull-base, when CAB induces the macroprolactinoma shrinkage. Endoscopic transsphenoidal surgery offers a safe, minimally invasive and efficient management of this complication, which allows to regularly perform the following steps of the therapeutical strategy against the prolactinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Colao A., Annunziato L., Lombardi G. Treatment of prolactinomas. Ann. Med. 1998, 30: 452–459.

    Article  CAS  PubMed  Google Scholar 

  2. Webster J., Piscitelli G., Polli A., Ferrari C.I., Ismail I., Scanlon M.F. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N. Engl. J. Med. 1994, 331: 904–909.

    Article  CAS  PubMed  Google Scholar 

  3. Molitch M.E. Medical treatment of prolactinomas. Endocrinol. Metab. Clin. North Am. 1999, 28: 143–169.

    Article  CAS  PubMed  Google Scholar 

  4. Colao A., Di Sarno A., Landi M.L., Cirillo S., Sarnacchiaro F., Facciolli G., Pivonello R., Cataldi M., Merola B., Annunziato L., Lombardi G. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J. Clin. Endocrinol. Metab. 1997, 82: 3574–3579.

    Article  CAS  PubMed  Google Scholar 

  5. Ferrari C.I., Abs R., Bevan J.S., Brabant G., Ciccarelli E., Motta T., Mucci M., Muratori M., Musatti L., Verbessem G., Scanlon M.F. Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin. Endocrinol. (Oxf.) 1997, 46: 409–413.

    Article  CAS  Google Scholar 

  6. Carroll W.R., Cohen S., Sullivan M.J. Spontaneous CSF rhinorrhea: an unusual presentation of a pituitary adenoma. Otolaryngol. Head Neck Surg. 1991, 104: 380–383.

    CAS  PubMed  Google Scholar 

  7. Obana W.G., Hodes J.E., Weinstein P.R., Wilson C.B. Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenoma: report of two cases. Surg. Neurol. 1990, 33: 336–340.

    Article  CAS  PubMed  Google Scholar 

  8. Spaziante R., Corriero G., Cappabianca P., Russo A., Donzelli R., Irace C., Carrabs G. Rinoliquorrea rivelatrice di un adenoma ipofisario invasivo associato ad empty sella. Caso clinico. Quad. Med. Chir. 1987, 3: 1–6.

    Google Scholar 

  9. Aronoff S.L., Daughaday W.H., Laws E.R. Jr. Bromocriptine treatment of prolactinomas. N. Engl. J. Med. 1979, 300: 1391 (letter).

    Article  CAS  PubMed  Google Scholar 

  10. Barlas O., Bayindir C., Hepgul K., Can M., Kiris T., Sencer E., Unal F., Aral F. Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature. Surg. Neurol. 1994, 41: 486–489.

    Article  CAS  PubMed  Google Scholar 

  11. Baskin D.S., Wilson C.B. CSF rhinorrhea after bromocriptine for prolactinoma. N. Engl. J. Med. 1982, 306: 178.

    CAS  PubMed  Google Scholar 

  12. Bronstein M.D., Musolino N.R., Benabou S., Marino R. Cerebropinal fluid rhinorrhea occurring in longterm bromocriptine treatment for macroprolactinomas. Surg. Neurol. 1989, 32: 346–349.

    Article  CAS  PubMed  Google Scholar 

  13. Hildebrandt G., Zierski J., Christophis P., Laun A., Schatz H., Lancranjan I., Klug N. Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma. Acta Neurochir. (Wien) 1989, 96: 107–113.

    Article  CAS  Google Scholar 

  14. Holness R.O., Shlossberg A.H., Heffernan L.P. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma. Neurology 1984, 34: 111–113.

    Article  CAS  PubMed  Google Scholar 

  15. Pascal-Vigneron V., Weryha G., Braun M., Morel-Jean J., Bisset S., Leclère J. La rhinorrhée et l’otorrhée: des complications rares du traitement médical del prolactinomes invasifs. Ann. Endocrinol. (Paris) 1993, 54: 347–351.

    Google Scholar 

  16. Jho H.D., Carrau R. Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J. Neurosurg. 1997, 87: 44–51.

    Article  CAS  PubMed  Google Scholar 

  17. Cappabianca P., Alfieri A., de Divitiis E. Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS). Min. Invas. Neurosurg. 1998, 41: 66–73.

    Article  CAS  Google Scholar 

  18. Rothrock J.F., Laguna J.F., Reynolds A.F. Rhinorrhea from untreated pituitary adenoma. Arch. Neurol. 1982, 39: 442–443.

    Article  CAS  PubMed  Google Scholar 

  19. Nutkiewicz A., De Feo D.R., Kohut R.I., Fierstien S. Cerebrospinal fluid rhinorrhea as a presentation of pituitary adenoma. Neurosurgery 1980, 6: 195–197.

    Article  CAS  PubMed  Google Scholar 

  20. Spaziante R., de Divitiis E. Cerebrospinal fluid rhinorrhea in patients with untreated pituitary adenomas. Surg. Neurol. 1991, 36: 150–151.

    Article  CAS  PubMed  Google Scholar 

  21. Leong K.S., Foy P.M., Swift A.C., Atkin S.L., Hadden D.R., MacFarlane I.A. CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin. Endocrinol. (Oxf.) 2000, 52: 43–49.

    Article  CAS  Google Scholar 

  22. Fager C.A. Nature and treatment of cerebrospinal fluid rhinorrhea in pituitary tumors. Surg. Clin. North Am. 1973, 53: 283–290.

    CAS  PubMed  Google Scholar 

  23. Pellegrini I., Rasolonjanahary R., Gunz G., Bertrand P., Delivet S., Jedynak C.P., Kordon C., Peillon F., Jaquet P., Enjalbert A. Resistance to bromocriptine in prolactinomas. J. Clin. Endocrinol. Metab. 1989, 69: 500–509.

    Article  CAS  PubMed  Google Scholar 

  24. Ciccarelli E., Grottoli S., Razzore P., Gaia D., Bertagna A., Cirillo S., Cammarota T., Camanni M., Camanni F. Long-term treatment with cabergoline, a new longlasting ergoline derivative in idiopathic or tumorous hyperprolactinemia and outcome of drug-induced pregnancy. J. Endocrinol. Invest. 1997, 20: 547–551.

    CAS  PubMed  Google Scholar 

  25. Colao A., Di Sarno A., Landi M.L., Scavuzzo F., Cappabianca P., Pivonello R., Volpe R., Di Salle F., Cirillo S., Annunziato L., Lombardi G. Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pre-treated with other dopamine agonists: a prospective study in 110 patients. J. Clin. Endocrinol. Metab. 2000, 85: 2247–2252.

    CAS  PubMed  Google Scholar 

  26. Colao A., Di Sarno A., Sarnacchiaro F., Ferone D., Di Renzo G., Merola B., Annunziato L., Lombardi G. Prolactinomas resistant to other dopamine agonists respond to chronic cabergoline treatment. J. Clin. Endocrinol. Metab. 1997, 83: 876–883.

    Article  Google Scholar 

  27. Verhelst J., Abs R., Maiter D., van den Bruel A., Vandeweghe M., Velkeniers B., Mockel J., Lamberigts G., Petrossians P., Coremans P., Mahler C., Stevenaert A., Verlooy J., Raftopoulos C., Beckers A. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J. Clin. Endocrinol. Metab. 1999, 84: 2518–2522.

    Article  CAS  PubMed  Google Scholar 

  28. Kennedy D.W. Functional endoscopic sinus surgery. Technique. Arch. Otolaryngol. 1985, 111: 643–649.

    Article  CAS  Google Scholar 

  29. Wigand M.E. Transnasal ethmoidectomy under endoscopic control. Rhinology 1981, 19: 7–15.

    CAS  PubMed  Google Scholar 

  30. Cappabianca P., Alfireri A., Colao A., Ferone D., Lombardi G., de Divitiis E. Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg. 1999, 9: 109–117.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Cappabianca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cappabianca, P., Lodrini, S., Felisati, G. et al. Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases. J Endocrinol Invest 24, 183–187 (2001). https://doi.org/10.1007/BF03343840

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343840

Key-words

Navigation